BLU-667 100 mg Pill - blue capsule-shape
Generic Name: pralsetinib
Pill with imprint BLU-667 100 mg is Blue, Capsule-shape and has been identified as Gavreto 100 mg. It is supplied by Genentech, Inc.
Gavreto is used in the treatment of non-small cell lung cancer; thyroid cancer and belongs to the drug class multikinase inhibitors. Gavreto 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BLU-667 100 mg
Gavreto
- Generic Name
- pralsetinib
- Imprint
- BLU-667 100 mg
- Strength
- 100 mg
- Color
- Blue
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 72064-0210 (Discontinued)
More about Gavreto (pralsetinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.